Showing results (221-230 of 229) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Science Translational Medicine|February 7, 2020
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in femalesYanxia Chen, Aubin Moutal, Edita Navratilova, et al.Cephalalgia : an International Journal of Headache|April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine preventionJennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.Cephalalgia : an International Journal of Headache|October 21, 2022
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster HeadacheJean Schoenen, Agneta Henriette Snoer, Roemer B Brandt, et al.Cephalalgia : an International Journal of Headache|December 2, 2025
Management of persistent idiopathic facial pain (PIFP) - An international Delphi studyErik Lindfors, Per Alstergren, Rafael Benoliel, et al.Current Sports Medicine Reports|January 10, 2019
Proceedings from the Ice Hockey Summit III: Action on ConcussionAynsley M Smith, Patrick A Alford, Mark Aubry, et al.Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|December 17, 2019
Proceedings From the Ice Hockey Summit III: Action on ConcussionAynsley M Smith, Patrick A Alford, Mark Aubry, et al.Neurology|February 10, 2025
Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi StudySeverin Schramm, Corinna Börner-Schröder, Miriam Reichert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.Pageof 23